LOGO
LOGO

Corporate News

Cyclacel Pharmaceuticals Stock Skyrockets 393%

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Cyclacel Pharmaceuticals, Inc. (CYCC) shares surged 393.05 percent to $16.32, despite the absence of any company-specific news or filings. The sharp rally has drawn significant market attention as trading volume exploded to 30.3 million shares, far surpassing its average volume of 213,616.

The stock opened at $4.58 and spiked as high as $18.35 before settling near $12.31 on the Nasdaq. It previously closed at $3.31, making today's move one of its most dramatic in recent history. Cyclacel now trades well above the lower end of its 52-week range of $3.08 to $597.60.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19